Cefozopran monohydrochloride
Specifications
113981-44-5CAS Number
(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochlorideIUPAC Name
C19H18ClN9O5S2Chemical Formula
552 g/molMolecular Weight
Cefozopran hydrochloride; Firstcin; 113981-44-5; Cefozopran monohydrochloride; 060I5C0GRC; (-)-1-(((6R,7R)-7-(2-(5-AMINO-1,2,4-THIADIAZOL-3-YL)GLYOXYLAMIDO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-1H-IMIDAZO(1,2-B)PYRIDAZIN-4-IUM HYDROXIDE INNER SALT, 7(SUP 2)-(Z)-(O-METHYLOXIME), HYDROCHLORIDE; DTXCID7028518; RefChem:124244; (6R,7R)-7-((Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetylamino)-3-(1H-imidazo(1,2-b)pyridazin-4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate monohydrochloride; DTXSID1048592; Cefozopran (hydrochloride); C19H18ClN9O5S2; UNII-060I5C0GRC; Cefozopranhydrochloride; SCE-2787.HCl; HY-B0771AR; orb1689942; SCHEMBL1229838; SCHEMBL9286286; HY-B0771A; GLXC-04479; (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochloride; MFCD00944908; AKOS037648568; Cefozopran (hydrochloride) (Standard); CCG-270009; CS-3504; CEFOZOPRAN HYDROCHLORIDE [MART.]; CEFOZOPRAN HYDROCHLORIDE [WHO-DD]; BS-14644; T4984; F864712; Q27236155; (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino-acetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride; Imidazo(1,2-b)pyridazinium, 1-((7-(((5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, chloride, (6R-(6alpha,7beta(Z)))-Synonyms
